NSIM
DFTX

North Star Investment Management’s Definium Therapeutics DFTX Stock Holding History

North Star Investment Management’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$143K Buy
7,571
+870
+13% +$14.8K 0.01% 546
2025
Q4 		$89.7K Hold
6,701
– – 0.01% 569
2025
Q3 		$79K Hold
6,701
– – 0.01% 573
2025
Q2 		$43.5K Sell
6,701
-2,700
-29% -$17.8K ﹤0.01% 664
2025
Q1 		$55K Hold
9,401
– – ﹤0.01% 596
2024
Q4 		$65.4K Hold
9,401
– – ﹤0.01% 573
2024
Q3 		$53.5K Buy
9,401
+6,901
+276% +$48K ﹤0.01% 585
2024
Q2 		$18K Buy
2,500
+350
+16% +$3.06K ﹤0.01% 734
2024
Q1 		$20.2K Buy
+2,150
New +$12.3K ﹤0.01% 741
2023
Q4 		– Sell
-14,860
Closed -$46.5K – 1257
2023
Q3 		$46.5K Buy
14,860
+2,810
+23% +$11.6K ﹤0.01% 596
2023
Q2 		$43K Buy
12,050
+2,925
+32% +$10.1K ﹤0.01% 630
2023
Q1 		$28.9K Buy
9,125
+9,092
+27,552% +$30.2K ﹤0.01% 707
2022
Q4 		$73 Hold
33
– – ﹤0.01% 1299
2022
Q3 		$0 Sell
33
-907
-96% -$8.71K ﹤0.01% 1161
2022
Q2 		$9K Buy
+940
New +$11.9K ﹤0.01% 851

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

North Star Investment Management's DFTX Position: Q1 2026 in Review

North Star Investment Management increased its Definium Therapeutics (DFTX) stake by 13% in Q1 2026, buying an estimated $14.8K and bringing the position to 7,571 shares worth $143K. The position accounts for 0.01% of the portfolio, ranked #546.

North Star Investment Management first reported a position in DFTX in Q2 2022 and has held it in 15 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • North Star Investment Management held 7,571 shares of Definium Therapeutics worth $143K as of Q1 2026.
  • North Star Investment Management bought 870 Definium Therapeutics shares in Q1 2026, an estimated $14.8K.
  • Definium Therapeutics made up 0.01% of North Star Investment Management's portfolio in Q1 2026, its #546 holding.
  • North Star Investment Management first reported a position in Definium Therapeutics in Q2 2022 and has held it in 15 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on North Star Investment Management's 13F filing for Q1 2026, filed 23 Apr 2026.